Literature DB >> 19248189

A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin.

Jun-Fen Fu1, Yan-Lan Fang, Li Liang, Chun-Lin Wang, Fang Hong, Guan-Ping Dong.   

Abstract

AIM: To create a rabbit model of pediatric nonalcoholic steatohepatitis (NASH) and to evaluate the role of adiponectin in the process.
METHODS: Thirty-two specific pathogen-free male New Zealand rabbits were divided randomly into three groups: (1) the normal control group (n = 10) was fed with standard diet for 12 wk; (2) the model group A (n = 11); and (3) model group B (n = 11) were fed with a high-fat diet (standard diet + 10% lard + 2% cholesterol) for 8 and 12 wk, respectively. Hepatic histological changes were observed and biochemical parameters as well as serum levels of adiponectin, interleukin (IL)-6, IL-10 and tumor necrosis factor (TNF)-alpha were measured.
RESULTS: Typical histological hepatic lesions of NASH were observed in both model groups described as liver steatosis, liver inflammatory infiltration, cytologic ballooning, perisinusoidal fibrosis and overall fibrosis. Compared with the normal control group, there were significant increases in model groups A and B in weight gain (1097.2 +/- 72.3, 1360.5 +/- 107.6 vs 928.0 +/- 58.1, P < 0.05, P < 0.01), liver weight (93.81 +/- 6.64, 104.6 +/- 4.42 vs 54.4 +/- 1.71, P < 0.01), Lg (ALT) (1.9 +/- 0.29, 1.84 +/- 0.28 vs 1.60 +/- 0.17, P < 0.01), and Lg (TG) (1.03 +/- 0.24, 1.16 +/- 0.33 vs 0.00 +/- 0.16, P < 0.01). Weight gain was much more in model group B than in model group A (1360.5 +/- 107.6 vs 1097.2 +/- 72.3, P < 0.05). But, there was no significant difference between the two groups concerning the other indexes. Pro-inflammatory cytokines (IL-6 and TNF-alpha) increased in model group B compared with that of control and model group A (IL-6: 1.86 +/- 0.21 vs 1.41 +/- 0.33, 1.38 +/- 0.42, P < 0.01; TNF-alpha: 1.18 +/- 0.07 vs 0.66 +/- 0.08, 0.86 +/- 0.43, P < 0.01, P < 0.05), whereas serum adiponectin and IL-10 decreased in model groups compared with that in the control (adiponectin: A: 21.87 +/- 4.84 and B: 21.48 +/- 4.60 vs 27.36 +/- 7.29, P < 0.05. IL-10: A: 1.72 +/- 0.38 and B: 1.83 +/- 0.39 vs 2.26 +/- 0.24, P < 0.01). Lg (TC) and the degree of liver fatty infiltration was an independent determinant of serum adiponectin level analyzed by stepwise multiple regressions, resulting in 29.4% of variances.
CONCLUSION: This rabbit model produces the key features of pediatric NASH and may provide a realistic model for future studies. Adiponectin level partially reflects the severity of liver steatosis, but not the degree of liver inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19248189      PMCID: PMC2653407          DOI: 10.3748/wjg.15.912

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  The role of cytokines in non-alcoholic steatohepatitis. A review.

Authors:  Ionel Copaci; Laurentiu Micu; Mihai Voiculescu
Journal:  J Gastrointestin Liver Dis       Date:  2006-12       Impact factor: 2.008

2.  Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding.

Authors:  Luca Busetto; Alberto Tregnaghi; Francesco De Marchi; Gianni Segato; Mirto Foletto; Giuseppe Sergi; Franco Favretti; Mario Lise; Giuliano Enzi
Journal:  Obes Res       Date:  2002-05

3.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.

Authors:  T P Combs; A H Berg; S Obici; P E Scherer; L Rossetti
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 4.  [Rabbit model for the study of human NASH].

Authors:  Kohji Otogawa; Norifumi Kawada
Journal:  Nihon Rinsho       Date:  2006-06

5.  Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children.

Authors:  Kohtaro Asayama; Hidemasa Hayashibe; Kazushige Dobashi; Norihiko Uchida; Takaya Nakane; Kohji Kodera; Akira Shirahata; Matsuo Taniyama
Journal:  Obes Res       Date:  2003-09

Review 6.  Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.

Authors:  Michael W Rajala; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

7.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

8.  Model of nonalcoholic steatohepatitis.

Authors:  Charles S Lieber; Maria A Leo; Ki M Mak; Youqing Xu; Qi Cao; Chaoling Ren; Anatoly Ponomarenko; Leonore M DeCarli
Journal:  Am J Clin Nutr       Date:  2004-03       Impact factor: 7.045

9.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

10.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.

Authors:  Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Atsushi Tsuchida; Takehiko Yokomizo; Shunbun Kita; Takuya Sugiyama; Makoto Miyagishi; Kazuo Hara; Masaki Tsunoda; Koji Murakami; Toshiaki Ohteki; Shoko Uchida; Sato Takekawa; Hironori Waki; Nelson H Tsuno; Yoichi Shibata; Yasuo Terauchi; Philippe Froguel; Kazuyuki Tobe; Shigeo Koyasu; Kazunari Taira; Toshio Kitamura; Takao Shimizu; Ryozo Nagai; Takashi Kadowaki
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962

View more
  13 in total

1.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

2.  Oxidative stress induced by portal vein embolization in fatty liver: Experimental study of a nonalcoholic steatohepatitis model.

Authors:  Yasutaka Baba; Sadao Hayashi; Kohei Nagasato; Michiyo Higashi; Nanako Tosuji; Shunro Sonoda; Takashi Yoshiura
Journal:  Biomed Rep       Date:  2018-08-08

3.  A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.

Authors:  Tomohiro Ogawa; Hideki Fujii; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 4.  Obesity, inflammation, and liver cancer.

Authors:  Beicheng Sun; Michael Karin
Journal:  J Hepatol       Date:  2011-11-25       Impact factor: 25.083

Review 5.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.

Authors:  Yaron Ilan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

6.  SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease.

Authors:  Marc-Olivier Deguise; Chantal Pileggi; Yves De Repentigny; Ariane Beauvais; Alexandra Tierney; Lucia Chehade; Jean Michaud; Maica Llavero-Hurtado; Douglas Lamont; Abdelmadjid Atrih; Thomas M Wishart; Thomas H Gillingwater; Bernard L Schneider; Mary-Ellen Harper; Simon H Parson; Rashmi Kothary
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-02-02

7.  Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring.

Authors:  M A Hyatt; D S Gardner; S Sebert; V Wilson; N Davidson; Y Nigmatullina; L L Y Chan; H Budge; M E Symonds
Journal:  Reproduction       Date:  2010-11-02       Impact factor: 3.906

Review 8.  Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.

Authors:  Sheila Cristina L Sanches; Leandra Naira Z Ramalho; Marlei Josiele Augusto; Deisy Mara da Silva; Fernando Silva Ramalho
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

9.  An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.

Authors:  Veronica Marin; Natalia Rosso; Matteo Dal Ben; Alan Raseni; Manuela Boschelle; Cristina Degrassi; Ivana Nemeckova; Petr Nachtigal; Claudio Avellini; Claudio Tiribelli; Silvia Gazzin
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

10.  Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease.

Authors:  Linqiang Zhang; Xiaoyun Wu; Shasha Liao; Yunhai Li; Zhiguo Zhang; Qing Chang; Ruyue Xiao; Bin Liang
Journal:  Biol Open       Date:  2016-10-15       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.